The relative mRNA abundance of miR-203, miR-542-3p, Survivin, and DNMT1, as well as the methylation status of miR-203 promoter in the clinical samples of NSCLC patients. The gene discussed is DNMT1; the disease is non-small cell lung carcinoma.